About ADR Solutions

Parasitology at the intersection of science and animal health.

ADR Solutions is a specialized parasitology R&D company. We combine deep biological understanding with high-throughput methods and AI to deliver screening, diagnostics, and platform development for the animal health industry. We operate within the UGA Innovation Gateway in Athens, Georgia.

The team

Three co-founders, complementary expertise.

A history of federally-funded collaborative research and a shared commitment to translating science into practical solutions for animal health.

Elyssa Campbell
Ph.D.
Co-founder & CEO

Research Faculty member in the Department of Infectious Diseases at the University of Georgia College of Veterinary Medicine, where she serves as Director of the Filariasis Research Reagent Resource Center. Her research focuses on filarial biology, anthelmintic drug screening, and the development of validated assay platforms for parasitic disease research. She provides filarial parasite life-cycle stages and specialized training to researchers and government organizations worldwide.

Leonor Sicalo Gianechini
DVM, Ph.D., DACVM
Co-founder

Assistant Professor in the Department of Infectious Diseases at the University of Georgia College of Veterinary Medicine. Her research focuses on gastrointestinal parasites of livestock, with an emphasis on anthelmintic resistance, parasite population genomics, and phenotyping and diagnostic tools. A board-certified veterinary parasitologist, her work spans field studies, laboratory assays, and genomic approaches to evidence-based parasite control in ruminant production systems.

Mostafa Zamanian
Ph.D.
Co-founder & CTO

Associate Professor in the Department of Pathobiological Sciences at the University of Wisconsin–Madison. He leads a federally funded research program (NIH, NSF, USDA) focused on host–pathogen interactions and drug discovery for neglected diseases. His group pairs experimental and computational approaches across human and animal disease systems to identify drug targets, resolve mechanisms of drug action and resistance, and build organismal and target-based platforms for drug discovery.

Want to learn more?

Let's set up a conversation about your program, your herd, or your target.

Get in touch →